News | 12 November 2012
Drug sales fall off a cliff after generic drugs come on the market. That's just a fact of life for drug developers. But at least when generics enter the market after a patent expires, investors can see it coming and adjust their valuations accordingly ...
Click on the link to read the full article at Motley Fool
(This link will open in a new window)